Pramipexole

Products Pramipexole is commercially available in tablet and sustained-release tablet form (Sifrol, Sifrol ER, generics). It has been approved in many countries since 1997; generics were released in 2010 and entered the market in January 2011. Sifrol ER sustained-release tablets were relaunched by the original manufacturer in 2010. Structure and properties Pramipexole (C10H17N3S, Mr = … Pramipexole

Piribedil: Effects, Uses & Risks

The drug piribedil belongs to the group of dopamine agonists and is used to treat Parkinson’s disease, with therapy aimed at alleviating the symptoms of the disease and halting further progression. What is piribedil? The drug piribedil belongs to the dopamine agonist group and is used to treat Parkinson’s disease. Piribedil has been used since … Piribedil: Effects, Uses & Risks

Dopamine Agonist: Effects, Uses & Risks

A dopamine agonist or dopamine antagonist is a drug that can stimulate dopamine receptors. Dopamine agonists are used to treat Parkinson’s disease, restless legs syndrome, and as emetics, among other conditions. What is a dopamine agonist? Dopamine agonists are used to treat Parkinson’s disease, restless legs syndrome, or as emetics, among other conditions. Dopamine agonists, … Dopamine Agonist: Effects, Uses & Risks

Pimozide: Effects, Uses & Risks

The drug pimozide is an active substance that belongs to the category of so-called antipsychotics. The drug is primarily available on the pharmaceutical market under the trade name Orap. In the majority of cases, the drug pimozide is used orally in the form of tablets. In this context, the drug is used primarily for the … Pimozide: Effects, Uses & Risks